Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma-authors' reply
- PMID: 34907557
- DOI: 10.1111/apt.16710
Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma-authors' reply
Comment on
-
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents.Aliment Pharmacol Ther. 2022 Feb;55(3):350-359. doi: 10.1111/apt.16685. Epub 2021 Nov 5. Aliment Pharmacol Ther. 2022. PMID: 34738664
-
Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting anti-virals in terms of prediction of hepatocellular carcinoma.Aliment Pharmacol Ther. 2022 Jan;55(1):122-123. doi: 10.1111/apt.16696. Aliment Pharmacol Ther. 2022. PMID: 34907552 No abstract available.
References
REFERENCES
-
- Ogawa E. Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma. Aliment Pharmacol Ther. 2022;55:122-123.
-
- Degasperi E, Perbellini R, D'Ambrosio R, et al. Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents. Aliment Pharmacol Ther. 2021. doi: 10.1111/apt.16685
-
- EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J Hepatol. 2018;69:182-236.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical